Back to news

Fundsmith Emerging - Compliance with Market Abuse Regulation

Back to news
RNS Number : 3609R
Fundsmith Emerging Equities Tst PLC
05 July 2022

Fundsmith Emerging Equities Trust plc

(the "Company")

Compliance with Market Abuse Regulation

5 July 2022

The Company confirms that:

a)         all inside information which the Directors and Company may have had has been notified to a Regulated Information Service ("RIS");

b)         the Company's net asset value per share is calculated and announced through a RIS on a daily basis; and

c)         the Company has no reason to believe that there will be any material difference between the net asset value per share as at close of business on 30 June 2022, which was announced on 1 July 2022, and the financial information to be published in the announcement of its interim results for the six months ended 30 June 2022.

The Company is, therefore, not prohibited from dealing in its own securities during the closed period, as defined by the Market Abuse Regulation, which will end on the date of the publication of its interim results for the six months ended 30 June 2022 which is expected to be on or around 5 August 2022.

If, in the period leading up to the announcement of these results, the Directors of the Company come into possession of any inside information, this will be notified to a RIS before any such transactions are undertaken.

For further information please contact:

Mark Pope

Frostrow Capital LLP

Company Secretary

020 3 008 4913

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCDZGGNRKVGZZG